Analyst Recommendations

Cowen & Co. analyst issues HOLD recommendation for CRM on August 29, 2024 07:36AM ET. The previous analyst recommendation was Hold.CRM was trading at $258.9 at issue of...

August 29, 2024   CRM -1.10%

UBS analyst issues NEUTRAL recommendation for CRM on August 29, 2024 08:36AM ET. The previous analyst recommendation was Neutral.CRM was trading at $258.9 at issue of the analyst...

August 29, 2024   CRM -1.10%

Jefferies analyst issues BUY recommendation for NVDA on August 29, 2024 08:23AM ET. The previous analyst recommendation was Buy.NVDA was trading at $125.61 at issue of the analyst...

August 29, 2024   NVDA 2.99%

Craig-Hallum analyst issues BUY recommendation for NVDA on August 29, 2024 08:26AM ET. The previous analyst recommendation was Buy.NVDA was trading at $125.61 at issue of the analyst...

August 29, 2024   NVDA 2.99%

UBS analyst issues NEUTRAL recommendation for HPQ on August 29, 2024 08:37AM ET. The previous analyst recommendation was Neutral.HPQ was trading at $34.76 at issue of the analyst...

August 29, 2024   HPQ -1.32%

Raymond James analyst issues STRONG BUY recommendation for CRM on August 29, 2024 08:47AM ET. The previous analyst recommendation was Strong Buy.CRM was trading at $258.9 at issue...

August 29, 2024   CRM -1.10%

Exane BNP Paribas analyst issues OUTPERFORM recommendation for CRM on August 29, 2024 08:47AM ET. The previous analyst recommendation was Outperform.CRM was trading at $258.9 at issue of...

August 29, 2024   CRM -1.10%

William Blair analyst issues MARKET PERFORM recommendation for ENPH on August 29, 2024 05:52AM ET. ENPH was trading at $123.65 at issue of the analyst recommendation.The overall analyst...

August 29, 2024   ENPH -15.15%

Raymond James analyst issues STRONG BUY recommendation for NVDA on August 29, 2024 05:39AM ET. The previous analyst recommendation was Strong Buy.NVDA was trading at $125.61 at issue...

August 29, 2024   NVDA 2.99%

Barclays analyst issues OVERWEIGHT recommendation for NVDA on August 29, 2024 05:45AM ET. The previous analyst recommendation was Overweight.NVDA was trading at $125.61 at issue of the analyst...

August 29, 2024   NVDA 2.99%